These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 8724995)

  • 1. Arginine vasopressin reduces the blood-brain transfer of L-tyrosine and L-valine: further evidence of the effect of the peptide on the L-system transporter at the blood-brain barrier.
    Reichel A; Begley DJ; Ermisch A
    Brain Res; 1996 Mar; 713(1-2):232-9. PubMed ID: 8724995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in regional blood-brain transfer of L-leucine elicited by arginine-vasopressin.
    Brust P
    J Neurochem; 1986 Feb; 46(2):534-41. PubMed ID: 3941319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in the blood-brain transfer of L-phenylalanine elicited by arginine vasopressin.
    Ermisch A; Reichel A; Brust P
    Endocr Regul; 1992 Mar; 26(1):11-6. PubMed ID: 1421202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulating blood-brain barrier interactions of amino acid-based anticancer agents.
    Killian DM; Gharat L; Chikhale PJ
    Drug Deliv; 2000; 7(1):21-5. PubMed ID: 10895416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the RBE4 cell line to explore carrier-mediated drug delivery to the CNS via the L-system amino acid transporter at the blood-brain barrier.
    Reichel A; Abbott NJ; Begley DJ
    J Drug Target; 2002 Jun; 10(4):277-83. PubMed ID: 12164376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Large neutral amino acids levels in primate cerebrospinal fluid do not confirm competitive transport under baseline conditions.
    Bongiovanni R; Mchaourab AS; McClellan F; Elsworth J; Double M; Jaskiw GE
    Brain Res; 2016 Oct; 1648(Pt A):372-379. PubMed ID: 27521685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in amino acid levels in rat plasma, cisternal cerebrospinal fluid, and brain tissue induced by intravenously infused arginine-vasopressin.
    Reichel A; Begley DJ; Ermisch A
    Peptides; 1995; 16(5):965-71. PubMed ID: 7479343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Saturable retention of vasopressin by hippocampus vessels in vivo, associated with inhibition of blood-brain transfer of large neutral amino acids.
    Reith J; Ermisch A; Diemer NH; Gjedde A
    J Neurochem; 1987 Nov; 49(5):1471-9. PubMed ID: 2959752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Twenty-four-hour variations in rat blood and brain levels of the aromatic and branched-chain amino acids: chronic effects of dietary protein content.
    Fernstrom JD; Fernstrom MH; Grubb PE
    Metabolism; 1987 Jul; 36(7):643-50. PubMed ID: 3600278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetics of arginine-vasopressin uptake at the blood-brain barrier.
    Zlokovic BV; Hyman S; McComb JG; Lipovac MN; Tang G; Davson H
    Biochim Biophys Acta; 1990 Jun; 1025(2):191-8. PubMed ID: 2364078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transport of L-phenylalanine and related amino acids at the ovine blood-brain barrier.
    Brenton DP; Gardiner RM
    J Physiol; 1988 Aug; 402():497-514. PubMed ID: 3236248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carrier-mediated transport of vasopressin across the blood-brain barrier of the mouse.
    Banks WA; Kastin AJ; Horvath A; Michals EA
    J Neurosci Res; 1987; 18(2):326-32. PubMed ID: 3694715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peptide receptors of the blood-brain barrier and substrate transport into the brain.
    Ermisch A
    Prog Brain Res; 1992; 91():155-61. PubMed ID: 1410400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinetic constants for blood-brain barrier amino acid transport in conscious rats.
    Miller LP; Pardridge WM; Braun LD; Oldendorf WH
    J Neurochem; 1985 Nov; 45(5):1427-32. PubMed ID: 4045456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transport, uptake, and metabolism of blood-borne vasopressin by the blood-brain barrier.
    Zlokovic BV; Banks WA; el Kadi H; Erchegyi J; Mackic JB; McComb JG; Kastin AJ
    Brain Res; 1992 Sep; 590(1-2):213-8. PubMed ID: 1422832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atypical amino acids inhibit histidine, valine, or lysine transport into rat brain.
    Tews JK; Harper AE
    Am J Physiol; 1983 Oct; 245(4):R556-63. PubMed ID: 6414314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo and in vitro evidence of blood-brain barrier transport of a novel cationic arginine-vasopressin fragment 4-9 analog.
    Tanabe S; Shimohigashi Y; Nakayama Y; Makino T; Fujita T; Nose T; Tsujimoto G; Yokokura T; Naito M; Tsuruo T; Terasaki T
    J Pharmacol Exp Ther; 1999 Aug; 290(2):561-8. PubMed ID: 10411563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Excitation of neurones in the rat paraventricular nucleus in vitro by vasopressin and oxytocin.
    Inenaga K; Yamashita H
    J Physiol; 1986 Jan; 370():165-80. PubMed ID: 3007746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood-brain transfer of L-phenylalanine declines after peripheral but not central nervous administration of vasopressin.
    Brust P; Diemer NH
    J Neurochem; 1990 Dec; 55(6):2098-104. PubMed ID: 2230811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Valine entry into rat brain after diet-induced changes in plasma amino acids.
    Tews JK; Greenwood J; Pratt OE; Harper AE
    Am J Physiol; 1987 Jan; 252(1 Pt 2):R78-84. PubMed ID: 3812733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.